March 24, 2009 - Abbott said today it initiated the next phase of the ABSORB clinical trial to evaluate the safety and ...
March 13, 2009 - A comprehensive analysis published this week in The Lancet from the ABSORB clinical trial demonstrated ...
March 10, 2009 - Abbott today launched the VOYAGER NC Coronary Dilatation Catheter, a next-generation balloon dilatation ...
Abbott's StarClose SE Vascular Closure System, a next-generation vessel closure device, is engineered to enable fast and ...
VOYAGER NC is Abbott's next-generation balloon dilatation catheter for the treatment of coronary artery disease ...
Abbott Vascular's XIENCE V Everolimus-Eluting Coronary is indicated for improving coronary luminal diameter in patients ...
January 28, 2009 - Data published this week in the online journal Circulation from the SPIRIT III U.S. pivotal trial ...
December 18, 2008 - Abbott this week said it started the SPIRIT Small Vessel, a clinical trial evaluating a 2.25mm size ...
December 15, 2008 - The FDA has approved Abbott's TRILIPIX (fenofibric acid) delayed-release capsules, the first and ...
October 30, 2008 - Abbott this week received a 2008 Chicago Innovation Award for its XIENCE V Everolimus Eluting ...